S100A1 and endometrial endometrioid carcinoma: For example, S100A1 serves as a favorable prognostic factor in endometrioid subtypes of ovarian carcinomas [45], whereas its expression is associated with poor prognosis in ovarian and endometrial endometrioid carcinomas [46].